The slip
PARKINSON RECEIPTno. 11650
27 Oct 2026, 06:32 UTColigodendrocytes, braak
predictionADARB2 in oligodendrocytes tracks Braak Lewy-body stage
registereda66bd0e184ff41f5
discovery-0.77 p=0.015 n=9
replication+0.19 p=0.630 n=9
neededp < 0.05 twice, same sign
did not replicate (discovery -0.77 p 0.015; held-out +0.19 p 0.630)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
DID NOT REPLICATE16516c7dbac8b75d7fee89b1…
follows a364e0102f40…
Covered by the on-chain checkpoint of receipt 11658 (2026-10-27 06:43 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 11650: ADARB2 in oligodendrocytes, braak
- power
- full sample -0.51 (p 0.032, n 18), 95% CI -0.79 to -0.05. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: -0.52 (p 0.027, n 18). holds up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.51 (p 0.032, n 18). not the mix.
- skeptic
- leave-one-out range -0.64 to -0.45, sign flips 0; without severely affected donors -0.51 (p 0.032, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ADARB2 in oligodendrocytes.
case closed: nothing better to follow up.